Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease.

MLA

Conrad, Máire A., et al. “Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease.” Inflammatory Bowel Diseases, vol. 22, no. 10, Oct. 2016, pp. 2425–31. EBSCOhost, https://doi.org/10.1097/MIB.0000000000000918.

APA

Conrad, M. A., Stein, R. E., Maxwell, E. C., Albenberg, L., Baldassano, R. N., Dawany, N., Grossman, A. B., Mamula, P., Piccoli, D. A., & Kelsen, J. R. (2016). Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 22(10), 2425–2431. https://doi.org/10.1097/MIB.0000000000000918

Chicago

Conrad, Máire A, Ronen E Stein, Elizabeth C Maxwell, Lindsey Albenberg, Robert N Baldassano, Noor Dawany, Andrew B Grossman, Petar Mamula, David A Piccoli, and Judith R Kelsen. 2016. “Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease.” Inflammatory Bowel Diseases 22 (10): 2425–31. doi:10.1097/MIB.0000000000000918.